Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials

BA Davison, SA Harrison, G Cotter, N Alkhouri… - Journal of …, 2020 - Elsevier
Background & Aims Liver biopsies are a critical component of pivotal studies in non-
alcoholic steatohepatitis (NASH), constituting inclusion criteria, risk stratification factors and …
被引用次数：339 相关文章

Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials

BA Davison, SA Harrison, G Cotter… - Journal of …, 2020 - journal-of-hepatology.eu
Background & Aims Liver biopsies are a critical component of pivotal studies in non-
alcoholic steatohepatitis (NASH), constituting inclusion criteria, risk stratification factors and …

[引用][C] Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials

BA Davison, SA Harrison, G Cotter, N Alkhouri… - Journal of …, 2020 - cir.nii.ac.jp
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials.

BA Davison, SA Harrison, G Cotter, N Alkhouri… - Journal of …, 2020 - europepmc.org
Methods Digitized slides of 678 biopsies from 339 patients with paired biopsies randomized
into the EMMINENCE study-examining a novel insulin sensitizer (MSDC-0602K) in NASH …

Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials

BA Davison, SA Harrison, G Cotter… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Background & aims Liver biopsies are a critical component of pivotal studies in non-
alcoholic steatohepatitis (NASH), constituting inclusion criteria, risk stratification factors and …

Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials

BA Davison, SA Harrison, G Cotter… - Journal of …, 2020 - journal-of-hepatology.eu
Background & Aims Liver biopsies are a critical component of pivotal studies in non-
alcoholic steatohepatitis (NASH), constituting inclusion criteria, risk stratification factors and …